Great Point Partners LLC Terns Pharmaceuticals, Inc. Transaction History
Great Point Partners LLC
- $409 Million
- Q1 2024
A detailed history of Great Point Partners LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 1,309,975 shares of TERN stock, worth $7.87 Million. This represents 2.1% of its overall portfolio holdings.
Number of Shares
1,309,975
Previous 1,309,975
-0.0%
Holding current value
$7.87 Million
Previous $8.5 Million
1.08%
% of portfolio
2.1%
Previous 1.8%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
118Shares Held
61MCall Options Held
155KPut Options Held
48.3K-
Orbimed Advisors LLC San Diego, CA7.62MShares$45.8 Million1.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.66MShares$40 Million5.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$36.7 Million1.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.43MShares$20.6 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY3.41MShares$20.5 Million1.92% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $226M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...